Hyloris Pharmaceuticals SA

€3.49As of Sun 8 Nov 2026, 12:00 UTC
EBR:HYLHealthcare
Country Belgium
PE (Fwd) •••
TSR 6Y CAGR (15.96%)
Div yield —
ROE (17.29%)
Biotechnology
Beta (5Y) 0.65
PE TTM —
TSR TTM (41.05%)
Mkt cap €97.72M
ROIC (13.25%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
€3.44
(1.42%)
(79.06%)
Hold 1|10|1|6|3
4Q25
1Q26
2Q26
3Q26
Earnings per share€
0.05
0.06
0.06
0.06
11.40%
20.10%
11.79%
12.22%
Revenue€M
4.188
4.125
4.235
4.411
(4.48%)
(5.70%)
(0.98%)
5.98%
Peers (US$109.7M)
Cap (US$)
PE
16.16M
7.436x
8.946M
2.587x
Capital
TTM
5Y
10Y
Leveragex
0.954
0.019
0.014
EBIT/Intx
2.496
0.933
0.718
Own earn%
(356.39)
(10.85)
22.37
Sh yield%
39.40
24.09
27.54
Owners
Insiders/Inst%
2.53
53.56
Short interest%
1.62
SBC / revenue%
5.43
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
6–12
$1 testx
—
Incr. ROIC%
43